CIENCIASMEDICASNEWS: Medical News | Medical Articles: Adjuvants

miércoles, 26 de junio de 2019

Medical News | Medical Articles: Adjuvants - Description and Types Available

	June 26, 2019
	Immunology
	The latest immunology news from News Medical

Adjuvants - Description and Types Available

Adjuvants are compounds or chemicals that can be added to immunizing peptides in order to promote and stimulate the immune response. One of their main advantages is that they increase the amount and quality of the antibody produced.

Read Full Article Here

			Targeting immune cells could potentially treat some kinds of brain tumor, study suggests Tumors arise when cells shake off their restraints and start to multiply out of control. But how fast a tumor grows does not depend solely on how quickly the cancer cells can divide, a new study has found.

			Study: Immune discovery may improve cancer therapies Cancer therapies that use immune cells to trigger the body to attack tumors could be improved by a molecule that boosts their function. Studies with mice have found the improved therapies produced a powerful anti-cancer immune response, which led to tumors shrinking.

	Electronic consultations in allergy and immunology may reduce need for specialist visits A study from Massachusetts General Hospital (MGH) researchers finds that electronic consultations (e-consults) in allergy and immunology can simplify the process of providing the most appropriate care, often reducing the need for in-person specialist visits. The paper, which has been published online in the Journal of Allergy and Clinical Immunology: In Practice, reports on the first two years of the MGH program and finds a significant reduction in the time needed to access specialist guidance.

	The immune system in women may be different from men finds study Research has shown that women have a different immune system from men and may respond differently to different immune disease processes. For example, studies have shown that women are eight times more likely to get autoimmune diseases such as multiple sclerosis, lupus and rheumatoid arthritis compared to men but have a lower risk of certain cancers such as colon, kidney, melanomas and lung cancers.

	Why are you seeing this?

	Researchers discover redundancies in immune cells Researchers at ETH Zurich have discovered redundancies in the biochemical signaling pathways of immune cells. This finding has important implications for advances in cancer immunotherapy, among other areas.

	Non-classical monocytes directly involved in regulation of immune response Non-classical monocytes were long thought to play a purely surveillance role in the immune system. With the aid of a novel marker, Ludwig-Maximilians-Universitaet in Munich researchers have now shown that they are directly involved in the regulation of immune response

	Researchers explore new immune checkpoint for head and neck cancer A checkpoint may delay travelers but it can help give cancer free rein by suppressing the natural immune response that should destroy it, researchers say. Now they want to learn more about how the enzyme CD73 -- an abundant checkpoint in our body that helps keep our immune system from getting out of control -- is helping often-aggressive head and neck cancers thrive.